Valuation: ConvaTec Group Plc

Capitalization 5.63B 4.84B 4.43B 4.19B 7.74B 544B 7.86B 52.53B 20.56B 257B 21.12B 20.68B 894B P/E ratio 2026 *
20.3x
P/E ratio 2027 * 15.4x
Enterprise value 6.82B 5.86B 5.37B 5.07B 9.37B 659B 9.52B 63.64B 24.9B 311B 25.59B 25.05B 1,083B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.42x
Free-Float
95.19%
Yield 2026 *
2.74%
Yield 2027 * 3.07%
1 day-0.09%
1 week+3.68%
Current month+1.61%
1 month-9.54%
3 months-6.38%
6 months-8.70%
Current year-11.92%
1 week 206.2
Extreme 206.2
216.6
1 month 199
Extreme 199
232.6
Current year 199
Extreme 199
259.3
1 year 199
Extreme 199
311.2
3 years 195.1
Extreme 195.1
311.2
5 years 165.3
Extreme 165.3
311.2
10 years 113.25
Extreme 113.25
349.1
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
President 65 01/02/2020
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.09%+3.68%-22.11%-5.31% 5.63B
-0.50%+5.43%-34.63%-18.87% 154B
-0.55%+2.55%-9.52%-12.52% 100B
+1.26%-3.04%+52.36%+65.11% 55.82B
-0.53%+3.55%-9.62%+52.69% 51.51B
0.00%+1.92%-16.82%-41.66% 40.49B
-3.85%-6.35% - - 30.65B
+6.71%+21.97%-18.20%-39.01% 27.57B
+0.52%+1.03%+41.81%-13.06% 21.58B
-0.43%+20.88%-13.45%+10.07% 21.76B
Average +0.25%+4.60%-3.35%-0.28% 50.93B
Weighted average by Cap. -0.04%+3.79%-9.52%-1.39%

Financials

2026 *2027 *
Net sales 2.57B 2.21B 2.03B 1.91B 3.54B 249B 3.59B 24.01B 9.4B 117B 9.66B 9.45B 409B 2.75B 2.36B 2.16B 2.04B 3.78B 265B 3.84B 25.64B 10.03B 125B 10.31B 10.09B 436B
Net income 281M 242M 221M 209M 386M 27.13B 392M 2.62B 1.03B 12.81B 1.05B 1.03B 44.61B 363M 312M 286M 270M 499M 35.09B 507M 3.39B 1.33B 16.57B 1.36B 1.33B 57.7B
Net Debt 1.19B 1.02B 937M 885M 1.64B 115B 1.66B 11.11B 4.35B 54.27B 4.47B 4.37B 189B 1.02B 877M 803M 759M 1.4B 98.55B 1.42B 9.52B 3.73B 46.52B 3.83B 3.75B 162B
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Date Price Change Volume
20/05/26 214.20 p -0.09% 7,934,799
19/05/26 214.40 p +1.23% 8,102,447
18/05/26 211.80 p +1.83% 9,122,153
15/05/26 208.00 p -0.57% 5,263,334
14/05/26 209.20 p +1.26% 4,101,292
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.880USD
Average target price
4.107USD
Spread / Average Target
+42.61%

Quarterly revenue - Rate of surprise